GE vs PPCB · P/E 44, rev $45.85B vs P/E 0.0, $3.9M cap
GE Aerospace (GE) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported GE revenue for 2025-12-31 was $45.85B. Net income was $8.70B. Revenue was up 324.1% from 2024-12-31 to 2025-12-31. GE currently screens at market cap $373.04B and trailing P/E 44.4.
PPCB does not have a complete income-statement cache yet.
GE currently screens at market cap $373.04B and trailing P/E 44.4. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the GE and PPCB stock pages for the full models.
Not investment advice.